dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, June 21st Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Health IT Homepage

Bruker unveils ParaVision 360 and AVANCE NEO solutions at ISMRM ParaVision 360 now provides preclinical imaging for MR and PET/MR

Non-traditional EHR tech companies vying for stake in market Google, Microsoft, Apple and Amazon among top companies

How can an insider threat interact with HIPAA regulated information? No hospital can afford an avoidable violation

Radiotherapy IT company CruxQS acquires RDS Will expand footprint for FlowBoard workflow management system

Philips-commissioned Future Health Index measures progress toward value-based healthcare FHI 2018 looked at data across 16 countries

Inspirata acquires GE company Caradigm Will enhance unstructured data processing and speed up CIDT development

Four tough questions about patient data that hospitals must answer How Cambridge Analytica's use of Facebook data highlights ambiguities

The moving image – imaging informatics’ opportunity to improve process Insights from Dr. Geraldine McGinty

First post-Maria permanent health clinics roll up on Puerto Rican shores Equipped with X-ray and telemedicine capabilities

Provenance and privacy: Healthcare execs talk AI best practices Providers need to understand what the algorithms are doing and how it will help them

Hype: Helping or hurting health care?

By Roy Smythe
From the February 2018 issue of DOTmed HealthCare Business News magazine

With new medical miracles being lauded by health care providers on a regular basis, it’s hard to differentiate between realistic benefits and overblown hype.

Promising research does not always equate to applicable clinical use in the near future. When the potential clinical effectiveness of a research endeavor is exaggerated, it may stymie the flow of financial, medical and regulatory support. Hyped-up claims can be a death sentence to once-promising work.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



If claims such as these do not pan out, those who invest in and fund medical research may be wary of supporting future ventures, and the hype ends in head-scratching as to why millions were invested in a no-show. More critically, hype can lead to heartbreaking situations for people waiting on the “next big thing” with the potential to save their lives, or the life of a loved one.

Medical advances cannot be made without research and trial and error, which often requires decades of work and significant investment to develop viable solutions. Artificial Intelligence (AI), machine learning, predictive analytics and natural language processing have great potential to help us solve some of the biggest challenges we’ve faced in health care over the past 500 years. But there is huge risk when we talk up shiny new technology and move too quickly to the health care delivery market, while the solutions themselves don’t deliver on their promise. If clinicians, providers and investors are not seeing results they may retrench. Admittedly, however, it’s also a fine line we walk, because when we don’t move quickly enough – waiting longer than necessary to bring potentially beneficial products and solutions forward – more patients lose out.

Finding the middle ground
It’s difficult to achieve the proper balance between the two extremes of such a dynamic health care innovation spectrum. We saw this same scenario play out with all the buzz around gene therapy 20 years ago. On one hand, there will always be products or technologies that promise far beyond what they’ll ever be able to deliver, leaving patients and investors at a loss. On the other, we have companies that might not seem that miraculous, but deliver on improvements and, more importantly, actually work. The middle ground may be somewhere that both gathers the interest of patients and investors and provides modest, yet successful, results. As with many aspects of life and business, finding the middle ground, if one actually even exists, can be tricky.
  Pages: 1 - 2 - 3 >>

Health IT Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有